FANSIDAR
LOE ApproachingNDAORALTABLETPriority Review
Approved
Oct 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 8h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FANSIDAR is an oral tablet small-molecule antimalarial combination therapy approved in 1981 by Roche. The drug's specific mechanism of action and exact indications are not detailed in available data, but it represents a legacy antimalarial product from the NDA era. It is indicated for malaria treatment and prevention in endemic populations.
LOE Approaching
This legacy product faces approaching loss of exclusivity with moderate competitive pressure (30%), suggesting a small, defensive team focused on maintaining market position in niche geographies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings reflect this product's mature, low-growth status; career opportunities are primarily in defensive commercial roles and supply chain management rather than innovation or expansion. Moving to FANSIDAR typically signals a career plateau unless paired with portfolio diversification or emerging market responsibility.
Brand ManagerField Sales Representative
Worked on FANSIDAR at Roche? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.